US 7709002
Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes
granted A61KA61K39/00A61K40/11
Quick answer
US patent 7709002 (Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K39/00, A61K40/11, A61K40/4253, A61K45/06